Méhtestrák: vizsgálatok itt: Németország
32 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
- Where
- Berlin, Bonn, Dresden, Essen, Kassel, Leipzig, Munich, Tuebingen
- Életkor
- 18 év and over
- People
- 480 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT06340568 · EU 2023-507525-42-00 - 3. fázisTaking peopleA Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Where
- Aachen, Berlin, Bonn, Dessau-Rosslau, Detmold, Dresden, Hamburg, Jena, Kassel, Kiel, Leipzig, Muenster, Munich, Saarbruecken, Trier
- Életkor
- 18 év and over
- People
- 1123 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06952504 · EU 2024-519331-42-00 - 3. fázisTaking peopleStudy to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
- Where
- Berlin, Bonn, Hamburg, Lemgo, Wiesbaden
- Életkor
- 18 év and over
- People
- 660 worldwide
- Run by
- Genmab
See details and how to joinNCT07166094 - 1/2. fázisTaking peopleEIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Where
- Berlin, Deggendorf, Hamburg
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT07262619 · EU 2026-525248-13-00 - 3. fázisTaking peopleA Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer in Adjuvant Setting
- Where
- Detmold, Dresden, Duesseldorf, Essen, Frankfurt Am Main, Freiburg, Hamburg, Ulm
- Életkor
- 18 év and over
- People
- 710 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT07022483 · EU 2024-519444-33-00 - 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Frankfurt
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Berlin, Dresden, Heidelberg, Heilbronn, Leipzig, Mainz, Muenster
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - 1/2. fázisTaking peopleA Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
- Where
- Bochum, München, Ulm
- Életkor
- 18 év and over
- People
- 245 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07186842 · EU 2025-522613-26-00 - 2. fázisTaking peopleAdjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- Where
- Schwäbisch Hall
- Életkor
- 18 év and over
- People
- 393 worldwide
- Run by
- Canadian Cancer Trials Group
See details and how to joinNCT05640999 - 3. fázisTaking peopleDESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Where
- Berlin, Chemnitz, Dessau-Rosslau, Dresden, Essen, Hamburg, Kassel, Leipzig, Mannheim, Muenster, Saarbruecken
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06989112 · EU 2023-508056-19-00 - 3. fázisTaking peopleRefining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features
- Where
- Berlin, Detmold, Dresden, Essen, Hamburg, Heidelberg, Kempten (Allgau), Leipzig, Ludwigsburg, Muenster, Munich, Schwaebisch Hall, Tuebingen, Ulm, Winnenden, Worms
- Életkor
- 18 év and over
- People
- 316 worldwide
- Run by
- Leiden University Medical Center
See details and how to joinNCT05255653 · EU 2023-503267-42-00 - 1/2. fázisTaking peopleStudy of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Where
- Bayern, Berlin, Heidelberg, Mainz
- Életkor
- 18 év to 130 év
- People
- 695 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05417594 · EU 2023-504984-17-00 - 1/2. fázisTaking peoplePhase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- Where
- Berlin, Essen, Freiburg im Breisgau, Hanover, Leipzig, Mannheim, Regensburg
- Életkor
- 18 év to 130 év
- People
- 622 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05797168 · EU 2022-502576-23-00 - 1/2. fázisTaking peopleThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Where
- Augsburg, Essen, Frankfurt am Main, Hamburg, Heidelberg
- Életkor
- 12 év and over
- People
- 300 worldwide
- Run by
- PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750 - 3. fázisTaking peopleA clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Magdeburg
- Életkor
- 18 év and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 · EU 2025-524160-38-00 - No phaseTaking peopleNIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometrial Cancer (DUOLife)
- Where
- Amberg, Bad Nauheim, Bautzen, Berlin, Bielefeld, Bonn, Borna, Bottrop, Brandenburg an der Havel, Braunschweig, Cologne, Dessau, Dresden, Ebersberg, Eggenfelden, Essen, Goslar, Greifswald, Gütersloh, Hamburg, Heilbronn, Homburg, Hösbach, Kiel, Krefeld, Kulmbach, Landshut, Leipzig, Limburg, Lüneburg, Magdeburg, Mainz, München, Neuruppin, Neuss, Nuremberg, Plauen, Rotenburg (Wümme), Siegen, Solingen, Stendal, Torgau, Traunstein, Unna, Wernigerode, Winnenden, Witten, Worms, Zittau
- Életkor
- 18 év to 130 év
- People
- 150
- Run by
- AstraZeneca
See details and how to joinNCT06890273 - 2. fázisTaking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Berlin, Essen, Hanover, München, Regensburg
- Életkor
- 18 év to 130 év
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - 1/2. fázisTaking peopleStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Where
- Cologne, Esslingen am Neckar, Moers, Nuremberg
- Életkor
- 18 év and over
- People
- 534 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06128551 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- Hamburg, Heilbronn, Munich
- Életkor
- 18 év and over
- People
- 2285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - 2. fázisTaking peopleA Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
- Where
- Essen, Muenster, Ulm
- Életkor
- 18 év and over
- People
- 350 worldwide
- Run by
- Acrivon Therapeutics
See details and how to joinNCT05548296 · EU 2025-524542-10-00 - 1. fázisTaking peopleA Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)
- Where
- Munich, Wuerzburg
- Életkor
- 18 év and over
- People
- 187 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07306559 · EU 2025-522913-45-00 - 3. fázisTaking peopleStudy to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Endometrial Cancer ( RAINFOL-03 )
- Where
- Berlin, Bonn, Chemnitz, Cologne, Detmold, Dresden, Duesseldorf, Hamburg, Leipzig, Munich, Schwaebisch Hall, Wiesbaden
- Életkor
- 18 év and over
- People
- 290 worldwide
- Run by
- Genmab A/S
See details and how to join2024-519818-31-01 · EU 2024-519818-31-01 - 3. fázisTaking peoplePuxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Where
- Amberg, Detmold, Dresden, Essen, Freiburg im Breisgau, Hamburg, Heidelberg, Heilbronn, Kassel, Mainz, Muenster, Paderborn, Regensburg, Ulm, Witten
- Életkor
- 18 év and over
- People
- 800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07044336 · EU 2024-518777-34-00 - 1. fázisTaking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Berlin
- Életkor
- 18 év and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - 2. fázisTaking peopleRelacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- Where
- Aachen, Berlin, Kempten
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- Corcept Therapeutics
See details and how to joinNCT06906341